These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL. Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510 [Abstract] [Full Text] [Related]
3. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake. Ruchała M, Sowiński J, Dolata M, Junik R, Gembicki M, Skiba A. Nucl Med Rev Cent East Eur; 2005 Dec; 8(1):28-32. PubMed ID: 15977144 [Abstract] [Full Text] [Related]
4. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC, Zanin DE, Zweers EJ. Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1837-41. PubMed ID: 12382370 [Abstract] [Full Text] [Related]
5. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Franklyn JA, Daykin J, Holder R, Sheppard MC. QJM; 1995 Mar 28; 88(3):175-80. PubMed ID: 7767667 [Abstract] [Full Text] [Related]
7. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT). Czarnywojtek A, Czepczynski R, Ruchala M, Wasko R, Zgorzalewicz-Stachowiak M, Szczepanek E, Zamyslowska H, Bartkowiak Z, Florek E, Sowinski J. Neuro Endocrinol Lett; 2009 Mar 28; 30(2):209-14. PubMed ID: 19675515 [Abstract] [Full Text] [Related]
8. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs. Esfahani AF, Kakhki VR, Fallahi B, Eftekhari M, Beiki D, Saghari M, Takavar A. Hell J Nucl Med; 2005 Mar 28; 8(3):158-61. PubMed ID: 16390021 [Abstract] [Full Text] [Related]
9. [Experience with ambulatory radioiodine therapy of hyperthyroidism]. Róka R, Séra T, Valkusz Z, Julesz J, Csernay L, Pávics L. Orv Hetil; 1999 Jun 06; 140(23):1291-5. PubMed ID: 10412264 [Abstract] [Full Text] [Related]
11. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit? Dietlein M, Moka D, Reinholz U, Schmidt M, Schomäcker K, Schicha H, Wellner U. Nuklearmedizin; 2007 Jun 06; 46(3):77-84. PubMed ID: 17549318 [Abstract] [Full Text] [Related]
12. [Treatment of hyperthyroidism with radioiodine: effects of administered dose on complications and thyroid function]. Pineda P, Michelsen H, Rivera M, Lillo R, Massardo T, Araya V, Sierralta P, Oviedo S, Liberman C. Rev Med Chil; 2000 May 06; 128(5):499-507. PubMed ID: 11008353 [Abstract] [Full Text] [Related]
16. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine. Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G. Clin Invest Med; 1999 Aug 06; 22(4):132-9. PubMed ID: 10497711 [Abstract] [Full Text] [Related]
17. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R, Rubio IG, Tomimori EK, Camargo RY, Knobel M, Medeiros-Neto G. Thyroid; 2009 Sep 06; 19(9):945-51. PubMed ID: 19678745 [Abstract] [Full Text] [Related]
18. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study. Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A. Clin Endocrinol (Oxf); 2005 Mar 06; 62(3):331-5. PubMed ID: 15730415 [Abstract] [Full Text] [Related]
19. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters. Huysmans DA, Buijs WC, van de Ven MT, van den Broek WJ, Kloppenborg PW, Hermus AR, Corstens FH. J Nucl Med; 1996 Dec 06; 37(12):2072-9. PubMed ID: 8970537 [Abstract] [Full Text] [Related]